- Home
- UNCY vs OVID Comparison
UNCY vs OVID Comparison
Compare UNCY & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- OVID
- Stock Information
- Founded
- UNCY 2016
- OVID 2014
- Country
- UNCY United States
- OVID United States
- Employees
- UNCY N/A
- OVID N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- UNCY Health Care
- OVID Health Care
- Exchange
- UNCY Nasdaq
- OVID Nasdaq
- Market Cap
- UNCY 74.2M
- OVID 88.9M
- IPO Year
- UNCY 2021
- OVID 2017
- Fundamental
- Price
- UNCY $3.94
- OVID $1.28
- Analyst Decision
- UNCY Strong Buy
- OVID Strong Buy
- Analyst Count
- UNCY 5
- OVID 4
- Target Price
- UNCY $55.20
- OVID $3.13
- AVG Volume (30 Days)
- UNCY 520.0K
- OVID 1.5M
- Earning Date
- UNCY 11-12-2025
- OVID 11-11-2025
- Dividend Yield
- UNCY N/A
- OVID N/A
- EPS Growth
- UNCY N/A
- OVID N/A
- EPS
- UNCY N/A
- OVID N/A
- Revenue
- UNCY N/A
- OVID $6,651,000.00
- Revenue This Year
- UNCY N/A
- OVID $708.13
- Revenue Next Year
- UNCY $4,481.14
- OVID N/A
- P/E Ratio
- UNCY N/A
- OVID N/A
- Revenue Growth
- UNCY N/A
- OVID 1070.95
- 52 Week Low
- UNCY $3.40
- OVID $0.24
- 52 Week High
- UNCY $11.00
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- UNCY 37.53
- OVID 73.32
- Support Level
- UNCY $4.23
- OVID $1.15
- Resistance Level
- UNCY $4.43
- OVID $1.35
- Average True Range (ATR)
- UNCY 0.19
- OVID 0.11
- MACD
- UNCY -0.01
- OVID -0.02
- Stochastic Oscillator
- UNCY 22.22
- OVID 68.18
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.